Growth Metrics

Kraig Biocraft Laboratories (KBLB) Amortization - Deferred Charges (2021 - 2022)

Kraig Biocraft Laboratories recorded quarterly Amortization - Deferred Charges of $398603.0 in Q4 2022, up 126.12% quarter-over-quarter from $176276.0 in Q3 2022, and down 24.79% year-over-year from $529963.0 in Q4 2021.

Kraig Biocraft Laboratories' Amortization - Deferred Charges history runs 2 years deep, the most recent figure standing at $398603.0 for Q4 2022.

  • In Q4 2022, Amortization - Deferred Charges fell 24.79% year-over-year to $398603.0; the TTM figure through Dec 2022 stood at $1.1 million (down 76.36% YoY), while the FY2022 annual figure was $1.1 million, down 76.36% from the prior year.
  • Amortization - Deferred Charges came in at $398603.0 for Q4 2022 at Kraig Biocraft Laboratories, up from $176276.0 in the prior quarter.
  • In the past five years, Amortization - Deferred Charges ranged from a high of $2.1 million in Q3 2021 to a low of $174669.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortization - Deferred Charges (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn -
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn -
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn -
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn -
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn -
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn -
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn -
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn -
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn -
10 Kraig Biocraft Laboratories - - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 398,603.00
Dec 31, 2022 398,603.00
Sep 30, 2022 176,276.00
Sep 30, 2022 176,276.00
Jun 30, 2022 174,669.00
Jun 30, 2022 174,669.00
Mar 31, 2022 362,032.00
Mar 31, 2022 362,032.00
Dec 31, 2021 529,963.00
Dec 31, 2021 529,963.00
Sep 30, 2021 2.09 Mn
Sep 30, 2021 2.09 Mn
Jun 30, 2021 1.85 Mn
Jun 30, 2021 1.85 Mn
Mar 31, 2021 235,492.00
Mar 31, 2021 235,492.00